Rankings
▼
Calendar
SANA FY 2023 Earnings — Sana Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena
SANA
Sana Biotechnology, Inc.
$900M
FY 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$293M
Net Income
-$283M
EPS (Diluted)
$-1.46
Cash Flow
Operating Cash Flow
-$254M
Free Cash Flow
-$274M
Stock-Based Comp.
$36M
Balance Sheet
Total Assets
$565M
Total Liabilities
$278M
Stockholders' Equity
$288M
Cash & Equivalents
$134M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$293M
-$273M
-7.5%
Net Income
-$283M
-$269M
-5.1%
← Q4 2022
All Quarters
Q1 2023 →